Skip to main content
TRS logo

TRS · Trimas Corp

Track TRS — free
$38.93 -0.19 (-0.49%)
Market Cap
$1.40B
Shares
35.87M
Volume · Oct 5 229.26K Avg daily vol (3M) 379.52K

Price & Indicators

Drag to pan · scroll to zoom
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$39.12 Open$38.95 Day$38.62–39.31 52W close$31.08–45.03 Avg vol 30d335K Short int3.5M · 9.9% float · 12.7d Short vol46% Last earningsOct 29, 2026 DataJan 2020–Oct 2026 Filing10-Q · Jul 31

Up next

Next earnings call
Oct 29, 2026 Scheduled · in 3 wks
filed Jul 31, 2026
call held Jul 30, 2026

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$664.37M
Trailing 12 months
Net income (TTM)
$905.20M
Trailing 12 months
Revenue growth YoY
+1.6%
Year over year
Operating margin
6.7%
Trailing 12 months
P / E (TTM)
1.6
Trailing earnings · reciprocal yield 61.4%
FCF yield
-1.1%
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
-11.5%
Year over year · fewer shares
Price change (1Y)
+4.4%
Trailing year
Short interest
9.9%
Latest settlement · 12.7 days to cover
View all 115 metrics

AI Brief

Q2 FY26 earnings call · Jul 30, 2026
Q2 FY26

TL;DR. TriMas (TRS) posted Q2 2026 net sales of $174.6 million (+1.6% YoY), adjusted operating profit up 29% to $14.9 million and adjusted EPS of $0.52 vs. $0.20, raised the low end of full-year 2026 adjusted EPS guidance to $1.60–$1.70, while Specialty Products operating margin guidance of 6%–8% reflects higher costs from labor ramp-up challenges.

Bullish
  • + Raised low end of full-year 2026 adjusted EPS guidance to $1.60–$1.70 (from $1.50–$1.70).
  • + Q2 adjusted operating profit increased 29% to $14.9 million with margin expanding 180 bps to 8.5%.
  • + Adjusted diluted EPS grew 160% to $0.52 from $0.20, supported by interest income and share repurchases.
  • + Repurchased more than 5 million shares since November 2025, reducing share count to ~35.9 million.
  • + Strong balance sheet with $1.24 billion cash and $846 million net cash position providing deployment flexibility.
  • + Specialty Products full-year sales growth guidance raised to 6%–9% (from prior 3%–6%) on strong order activity.
Bearish
  • − Specialty Products Q2 operating margin declined to 2.2% from 4.4% due to labor ramp-up and manufacturing inefficiencies.
  • − Specialty Products full-year operating margin guidance of 6%–8% reflects higher second-quarter costs.
  • − Q2 free cash flow was a use of $12.9 million vs. a $7.7 million source in prior year period.
  • − Resin cost under-recovery pressured Q2 packaging margins by ~100 bps.

AI-generated from the earnings call and 8-K · may contain errors · not investment advice

Equibles Rating

blended score · not investment advice
Overall
Buy
SellHoldBuy
Technical Buy Momentum Neutral Sentiment Bullish Fundamentals Strong Quant / Vol Moderate
Market backdrop VIX 15.3 · calm Equity put/call 0.58
Technical
price trend
Buy
50 / 200-day cross No cross
Price vs 200-day avg +2%
above
Price vs 50-day avg −0%
below
RSI (14) 51
neutral
MACD trend Positive
52-week position 58%
mid-range
Momentum
relative strength
Neutral
1-month return +1%
trailing
6-month return +1%
trailing
YTD return +10%
this year
Relative strength −11%
vs S&P · 6-mo
Sentiment
smart money
Bullish
Trend (MA cross) No cross
50d $39 › 200d $38 — 50d above 200d
Institutional flow Accumulating
1 of 207 funds reported for Sep 30 · net +30 sh shares
Insider flow Accumulating
Net +$2.5K over 90 days · 0% sells
Short interest Rising
9.87% of float · ▲ +4.7% MoM · 12.7 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
207 holders — near 3-yr high, broad support
Squeeze score 67
elevated · 0–100
Fundamentals
Strong
Revenue growth +2%
Y/Y
Gross margin 21%
expanding
EPS growth +392%
Y/Y
Valuation P/E 1.6
below peers
Buyback $76.5M
remaining
Balance sheet $272.3M
net debt
Quant / Vol
risk profile
Moderate
Volatility 29%
annualized · 1-yr
Max drawdown −22%
past year
ATR 2.5%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Beat or met 0 of last 3
Latest guidance · from the 8-K filed Jul 30, 2026
full-year 2026
Adjusted diluted earnings per share Initiated $1.60 – $1.70
Sales growth across combined Packaging and Specialty Products bu Initiated 3% – 6%
Twelve months ended December 31, 2026
Diluted earnings per share Initiated $1.08 – $1.18
prior FY $2.95 midpoint −61.7% Y/Y
Guided vs delivered · last 3 settled
Diluted earnings per share (GAAP) Twelve months ended December 31, 2024
guided $1.40 – $1.60
$0.60 Miss −60.0%
Diluted earnings per share (GAAP) twelve months ended December 31, 2023
guided $1.67 – $1.87
$0.97 Miss −45.2%
Full year EPS full year
guided $2.18 – $2.27
$1.32 Miss −40.7%

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Buy
0 · 4 · 2
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
+2% Bullish
Price vs 50-day avg
−0% Neutral
RSI (14)
51 Neutral
MACD trend
Positive Bullish
52-week position
58% Neutral
Market signals — smart money & positioning
Bullish · 3 of 6
Trend (MA cross) No cross
50d $39 › 200d $38 — 50d above 200d
Institutional flow Accumulating
1 of 207 funds reported for Sep 30 · net +30 sh shares
Insider flow Accumulating
Net +$2.5K over 90 days · 0% sells
Short interest Rising
9.87% of float · ▲ +4.7% MoM · 12.7 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
207 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $31 Now $39 · 58% Range high $45
vs 200-day avg +2% vs 50-day avg 0%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

Earlier KPI extraction records exist, but do not meet the current evidence-completeness requirements. No current verified series is available. Earlier figures remain withheld until revalidated; this is not evidence that the company reports no KPIs.

Versus peers

Packaging & Containers — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
TRS
Trimas Corp
this stock
$1.40B +10.4% +2.4% 1.6 9.9%
SW
Smurfit Westrock plc
$24.34B +10.0% +47.7% 49.4 4.6%
PKG
Packaging Corp Of America
$21.13B +10.8% +7.2% 30.8 3.8%
AMCR
Amcor plc
$19.78B — +56.6% 18.0 4.7%
IP
International Paper Co /New/
$18.55B -18.8% +49.3% — 8.7%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
207
% held
83.3%
Reported
1 of 207
Top holder
BlackRock, Inc.
Held Float
View
Held by Funds
Fund positions
246
View
Short & Settlement
Short Interest Rising
Shares short
3.5M
Days to cover
12.7d
Change
+158.0K sh
View
Short Volume
Short vol %
46%
As of
Oct 5, 2026
Short Total
View
Fails to Deliver
FTD shares
51
Value
$2.0K
As of
Sep 9, 2026
View
Off-Exchange
Off-exchange %
34.8%
Week of
Aug 31, 2026
Off-exch Lit
View
Smart Money
Insider Trades Net buying
Net (90d)
+$2.5K
Buyers / Sellers
1 / 0
Buyers Sellers
View
Financials
Financials
Revenue (FY)
$645.7M
Net income (FY)
$120.1M
EPS diluted
$2.95
View
Buybacks
Authorized
$150.0M
Remaining
$76.5M
Spent Remaining
View
Filings
SEC Filings
Latest
10-Q
Filed
Jul 31, 2026
This year
11
View
Proposed Sales
Value
$675.5K
Shares
15.0K
Filed
Jun 30, 2026
View
Earnings & Events
Webcasts Upcoming
Next webcast
Oct 29, 2026
Last webcast
Jul 30, 2026
View
Investor Relations
Latest news
TriMas Announces Third Quarter 20…
Published
Oct 5, 2026
Upcoming events
1
View

Performance

5D 20D 120D MTD YTD
TRS -0.1% +0.7% +0.7% +1.4% +10.4%
SPY -0.2% -0.5% +12.2% +0.9% +12.9%
vs SPY +0.1% +1.2% -11.5% +0.4% -2.5%

Capital returns

Buyback program · as of Jun 30, 2026
Authorized
$150.00M
Spent (derived)
$73.50M
Remaining
$76.50M
Spent Remaining

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 842633 CUSIP 896215209 13F (30d) 5 filings 5 filers Visit website Investor relations